Sign in

CIK 0001625297

  • Large accelerated filer

Supernus, Inc.

Sign in to watch
Ticker
SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412520873
Phone
+1 804-379-1090
Business address
9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Former names
Indivior Pharmaceuticals, Inc., INDIVIOR PLC
  1. 4 Grant or award Director acquired 3,722 shares (grant or award)
  2. 4 Grant or award Director acquired 3,722 shares (grant or award)
  3. 15-12G Other 15-12G
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. S-8 POS Other Post-effective Amendment
  6. S-8 POS Other Post-effective Amendment
  7. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Regulation FD disclosure · Other events
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 8-K Event Regulation FD disclosure
  10. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  11. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  12. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  13. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  14. 4 Open-market buy Director bought 1,771 shares at $35.39 ($62,680)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 6 of 29 · 572 filings